0000899243-19-016513.txt : 20190611
0000899243-19-016513.hdr.sgml : 20190611
20190611190759
ACCESSION NUMBER: 0000899243-19-016513
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190228
FILED AS OF DATE: 20190611
DATE AS OF CHANGE: 20190611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Snodgres Jon
CENTRAL INDEX KEY: 0001613498
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14656
FILM NUMBER: 19892178
MAIL ADDRESS:
STREET 1: REPLIGEN CORPORATION, 41 SEYON STREET
STREET 2: BUILDING #1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02435
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REPLIGEN CORP
CENTRAL INDEX KEY: 0000730272
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 042729386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7814499560
MAIL ADDRESS:
STREET 1: 41 SEYON STREET
STREET 2: BUILDING 1, SUITE 100
CITY: WALTHAM
STATE: MA
ZIP: 02453
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2019-02-28
2019-03-04
0
0000730272
REPLIGEN CORP
RGEN
0001613498
Snodgres Jon
C/O REPLIGEN CORPORATION
41 SEYON ST., BLDG 1, STE 100
WALTHAM
MA
02453
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
59.52
2019-02-28
4
A
0
5681
0.00
A
2029-02-28
Common Stock
5681
5681
D
One third of the stock options will vest and become exercisable annually on February 28, 2020, February 28, 2021 and February 28, 2022.
This Form 4/A amends a Form 4 filed on 3/4/2019 to correct the number of shares acquired from 5,653 to 5,681 due to the incorrect Black Scholes fair value used to calculate the number of stock options granted.
/s/ Jeffrey P. Leduc (Attorney in Fact)
2019-06-11